Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Human Identification Market, by End User
1.4.2 Europe Human Identification Market, by Product
1.4.3 Europe Human Identification Market, by Application
1.4.4 Europe Human Identification Market, by Technology
1.4.5 Europe Human Identification Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Human Identification Market
Chapter 5. Europe Human Identification Market by End User
5.1 Europe Forensic Laboratories Market by Country
5.2 Europe Research Centers, Academic & Government Institutes Market by Country
Chapter 6. Europe Human Identification Market by Product
6.1 Europe Assay Kits and Reagents Market by Country
6.2 Europe Instruments Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Human Identification Market by Application
7.1 Europe Forensic Applications Market by Country
7.2 Europe Paternity Identification Market by Country
7.3 Europe Others Market by Country
Chapter 8. Europe Human Identification Market by Technology
8.1 Europe Polymerase Chain Reaction Market by Country
8.2 Europe Next-Generation Sequencing Market by Country
8.3 Europe Capillary Electrophoresis Market by Country
8.4 Europe Others Market by Country
Chapter 9. Europe Human Identification Market by Country
9.1 Germany Human Identification Market
9.1.1 Germany Human Identification Market by End User
9.1.2 Germany Human Identification Market by Product
9.1.3 Germany Human Identification Market by Application
9.1.4 Germany Human Identification Market by Technology
9.2 UK Human Identification Market
9.2.1 UK Human Identification Market by End User
9.2.2 UK Human Identification Market by Product
9.2.3 UK Human Identification Market by Application
9.2.4 UK Human Identification Market by Technology
9.3 France Human Identification Market
9.3.1 France Human Identification Market by End User
9.3.2 France Human Identification Market by Product
9.3.3 France Human Identification Market by Application
9.3.4 France Human Identification Market by Technology
9.4 Russia Human Identification Market
9.4.1 Russia Human Identification Market by End User
9.4.2 Russia Human Identification Market by Product
9.4.3 Russia Human Identification Market by Application
9.4.4 Russia Human Identification Market by Technology
9.5 Spain Human Identification Market
9.5.1 Spain Human Identification Market by End User
9.5.2 Spain Human Identification Market by Product
9.5.3 Spain Human Identification Market by Application
9.5.4 Spain Human Identification Market by Technology
9.6 Italy Human Identification Market
9.6.1 Italy Human Identification Market by End User
9.6.2 Italy Human Identification Market by Product
9.6.3 Italy Human Identification Market by Application
9.6.4 Italy Human Identification Market by Technology
9.7 Rest of Europe Human Identification Market
9.7.1 Rest of Europe Human Identification Market by End User
9.7.2 Rest of Europe Human Identification Market by Product
9.7.3 Rest of Europe Human Identification Market by Application
9.7.4 Rest of Europe Human Identification Market by Technology
Chapter 10. Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 SWOT Analysis
10.2 Promega Corporation
10.2.1 Company Overview
10.2.2 SWOT Analysis
10.3 Hamilton Company
10.3.1 Company Overview
10.3.2 SWOT Analysis
10.4 Bio-Rad laboratories, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Qiagen N.V.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.5.6 SWOT Analysis
10.6 SecuriGene Technologies Inc.
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 AutoGen, Inc
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Partnerships, Collaborations, and Agreements:
10.7.3 SWOT Analysis
10.8 Innogenomics Technologies, LLC
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Carolina Biological Supply Company
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Genetak Biopharma GmbH
10.10.1 Company Overview
Unique Offerings 